Spectral Med Inc (TO:EDT) — Market Cap & Net Worth
Market Cap & Net Worth: Spectral Med Inc (EDT)
Spectral Med Inc (TO:EDT) has a market capitalization of $284.46 Million (CA$393.23 Million) as of May 2, 2026. Listed on the TO stock exchange, this Canada-based company holds position #15183 globally and #458 in its home market, demonstrating a -0.73% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Spectral Med Inc's stock price CA$1.36 by its total outstanding shares 289138820 (289.14 Million). Analyse cash efficiency ratio of Spectral Med Inc to see how efficiently the company converts income to cash.
Spectral Med Inc Market Cap History: 2015 to 2026
Spectral Med Inc's market capitalization history from 2015 to 2026. Data shows growth from $169.42 Million to $284.46 Million (5.16% CAGR).
Spectral Med Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Spectral Med Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
45.75x
Spectral Med Inc's market cap is 45.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $169.42 Million | $3.09 Million | -$9.52 Million | 54.85x | N/A |
| 2016 | $57.52 Million | $3.54 Million | -$10.15 Million | 16.23x | N/A |
| 2017 | $79.48 Million | $3.67 Million | -$4.08 Million | 21.66x | N/A |
| 2018 | $59.61 Million | $3.84 Million | -$2.49 Million | 15.52x | N/A |
| 2019 | $150.59 Million | $2.87 Million | -$4.86 Million | 52.51x | N/A |
| 2020 | $84.71 Million | $2.10 Million | -$9.10 Million | 40.32x | N/A |
| 2021 | $46.01 Million | $2.00 Million | -$8.79 Million | 23.05x | N/A |
| 2022 | $77.39 Million | $1.67 Million | -$11.28 Million | 46.42x | N/A |
| 2023 | $88.89 Million | $1.60 Million | -$15.66 Million | 55.63x | N/A |
| 2024 | $104.58 Million | $2.29 Million | -$15.40 Million | 45.75x | N/A |
Competitor Companies of EDT by Market Capitalization
Companies near Spectral Med Inc in the global market cap rankings as of May 2, 2026.
Key companies related to Spectral Med Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Spectral Med Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Spectral Med Inc's market cap moved from $169.42 Million to $ 284.46 Million, with a yearly change of 5.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$284.46 Million | -5.56% |
| 2025 | CA$301.19 Million | +188.00% |
| 2024 | CA$104.58 Million | +17.65% |
| 2023 | CA$88.89 Million | +14.86% |
| 2022 | CA$77.39 Million | +68.18% |
| 2021 | CA$46.01 Million | -45.68% |
| 2020 | CA$84.71 Million | -43.75% |
| 2019 | CA$150.59 Million | +152.63% |
| 2018 | CA$59.61 Million | -25.00% |
| 2017 | CA$79.48 Million | +38.18% |
| 2016 | CA$57.52 Million | -66.05% |
| 2015 | CA$169.42 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Spectral Med Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $284.46 Million USD |
| MoneyControl | $284.46 Million USD |
| MarketWatch | $284.46 Million USD |
| marketcap.company | $284.46 Million USD |
| Reuters | $284.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Spectral Med Inc
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device … Read more